People channel feed – Endpoints News

People channel feed

Fearless: Julian Adams looks to steer Gamida Cell through PhIII, an IPO and a market launch

8 years ago

Award-winning sepsis project gets $13M and a shot at reopening an R&D avenue as FDA pitches out old gold standard

8 years ago

ImmusanT scores a $40M round for PhII celiac study, with biotech vet Tom Daniel joining the board

8 years ago

Pfizer CEO Read hands off drug development responsibilities to his hand picked successor

8 years ago

Ex-Eli Lilly exec Azar lands HHS nomination as Trump champions lower drug prices

8 years ago

Ex-Shire exec Phil Vickers joins the migration to startups, taking the reins at an immuno-oncology biotech

8 years ago

Exodus of Ex-Googlers at Silicon Valley's sexiest biotech startups

8 years ago

Struggling GSK recruits cancer drug guru Hal Barron as its new R&D chief

8 years ago

Feds charge Osiris execs with cooking the books as stock price soared

8 years ago

GSK R&D chief Vallance is out as its new CEO changes direction under a new crew

8 years ago

Shkreli out, Cuban in: Twitter proves essential for biotech rebel Ethan Perlstein

8 years ago

Grail CSO Vikram Bajaj jumps to VC firm Foresite, takes lead on personalized meds

8 years ago

Buzz: Will Brent Saunders split up Allergan if he loses the Restasis patent fight?

8 years ago

Biotech bad boy Martin Shkreli isn't getting his $5M in bail money back anytime soon

8 years ago

Peer Review: Eyeing a $350M venture fund, Nextech recruits Third Rock’s Jakob Loven for the team

8 years ago

Unicorn hunter Vivek Ramaswamy has cooked up a new deal with AstraZeneca. But what is it?

8 years ago

Sean Parker’s cancer institute keeps growing with some “mind blowing” new research projects

8 years ago

After jumping ship at Eli Lilly, Politico reports Alex Azar may soon land top HHS job

8 years ago

Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib

8 years ago

Former FDA chief von Eschenbach steps up his advisory role at Malin

8 years ago

With just a little encouragement, biotech investors are ready to fall in love again

8 years ago

Abbas Hussain swings from top GSK pharma post to powerhouse Chinese private equity player C-Bridge

8 years ago

Biotech scientist/entrepreneur Saurabh Saha makes an unusual return to the arms of a big — and excessively discreet — R&D group

8 years ago

Top scientists and BD execs craft Cullinan, a $150 million R&D portfolio shop focused on cancer

8 years ago

First page Previous page 91 92 939495 96 97 Next page Last page